Background To examine the effect of multicomponent exercise program on memory function
in older adults with mild cognitive impairment (MCI), and identify biomarkers associated with …

The cellular distribution of malondialdehyde (MDA) was assessed immunohistochemically
in brain specimens from young and normal elderly subjects as well as patients with …

Background and Purpose Dementia with Lewy bodies (DLB) needs to be distinguished from
Alzheimer’s disease (AD) because of important differences in patient management and …

Alzheimer’s disease (AD) is the most common and devastating dementia. Simple and
practical biomarkers for AD are urgently required for accurate diagnosis and to facilitate the …

Biomarkers useful for the predementia stages of Alzheimer’s disease are needed.
Electroencephalography and magnetoencephalography (MEG) are expected to provide potential …

To determine the characteristics of cerebral glucose metabolism in Parkinson's disease
patients with visual hallucinations, group comparison studies using [ 18 F]fluorodeoxyglucose …

Background Cognitive function of Machado-Joseph disease (MJD) patients has not been
clarified. Objectives To determine the characteristics of cognitive dysfunction in MJD patients …

Objective: Using 6-[ 18 F]fluoro-l-dopa (FDOPA) and [ 18 F]fluorodeoxyglucoce (FDG) positron
emission tomography (PET), multiple regression analyses were performed to determine …

Background and purpose We previously reported the usefulness of iodine-123
metaiodobenzylguanidine ( 123 I-MIBG) myocardial scintigraphy for differentiation of dementia with …

Background: 18F-FDG-PET is defined as a biomarker of neuronal injury according to the
revised National Institute on Aging–Alzheimer’s Association criteria. Objective: The objective of …